​WG5: DATA SHARING AND DATA MANAGEMENT IN PPD

​Leader: Bruno de Sousa (Portugal)Co-Leader: Thomas Kneib (Germany) Objectives: Promote a framework for quality of data and data sharing among participant countries; Explore data management and analysis strategies. Tasks: i) Establish a framework to build a pan-European database in PPD, incorporating regulatory, legal, ethical and patient governance, to be adopted by in future research; ii) […]

WG4: ETHICAL STANDARDS AND PROCEDURES FOR CLINICAL RESEARCH IN PPD

Leader: Dr Susanne Uusitalo  Objectives: Improve the protection of human subjects in all aspects of research in PPD Tasks: i) Identify emerging ethical and legal issues in PPD, related to patient recruitment, sampling, informed consent, sharing of data, biological samples and personal data protection; ii) Discuss primary ethical concerns in human research and specificities in pregnancy, […]

​WG3: NEUROIMAGING AND NEUROPHYSIOLOGICAL DATA ACQUISITION AND ANALYSIS IN PPD

Leader: Anna-Lisa Schuler (Italy)Co-leader:  ​Former Leader: Chris Baeken (Belgium)Former Co-Leader: Marie-Anne Vanderhasselt (Belgium) Objectives: Establish the best approaches to study the neuronal underpinnings of PPD in women and the neural correlates of its impact in the newborn-infants. Tasks: i) Synthesis of the best practices in neuroimaging and neurophysiological data acquisition and analysis; ii) Develop innovative methods of analysis […]

​WG2: ASSESSMENT APPROACHES AND METHODS IN PPD

Leader: Ilaria Lega (Italy)Co-Leader: Alkistis Skalkidou (Sweden) Previous Leader: Colin Martin (UK)Previous Co-Leader: Helena Moreira (Portugal) Objectives: Appraise, develop and define standard procedures to: i) assess women diagnosed with PPD (pre- and post-treatment); ii) collect genetic and epigenetic biomarkers; iii) assess the impact of PPD in the newborn-infant development (0-12 months); iv) assess interpersonal functioning […]

​WG1: PREVENTION AND TREATMENT STRATEGIES IN PPD

Leader: Rena Bina (Israel)Co-Leader: Ana Uka (Albania) Previous leadersLeader (2021-2022): Sandra Nakić Radoš (Croatia)Previous leader (2019-2021): Ana Fonseca (Portugal)Previous Co-Leader (2019-2021): Sandra Nakić Radoš (Croatia) Objectives: Synthesize current knowledge concerning diagnosis criteria and strategies for prevention and treatment of PPD, including knowledge about well-established interventions and new lines of research, its cost-effectiveness and organizational impact.Tasks: i) […]